about
Asenapine versus placebo for schizophreniaAsenapine versus placebo for schizophreniaSchizotypy as an organizing framework for social and affective sciencesCharacterizing thalamo-cortical disturbances in schizophrenia and bipolar illnessEmotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanismsDopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and FutureSmoking in schizophrenic patients: A critique of the self-medication hypothesis.Association between two distinct executive tasks in schizophrenia: a functional transcranial Doppler sonography study.Altered global brain signal in schizophreniaIdentification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathwaysTrajectories and antecedents of treatment response over time in early-episode psychosis.Using an uncertainty-coding matrix in Bayesian regression models for haplotype-specific risk detection in family association studies.Cardiac Coherence Training to Reduce Anxiety in Remitted Schizophrenia, a Pilot StudyAssessment of behaviors modeling aspects of schizophrenia in Csmd1 mutant miceRegulation of interleukin-6 and leptin in schizophrenia patients: a preliminary analysis.Developmental trajectories of schizotypal personality disorder-like behavioural manifestations: a two-year longitudinal prospective study of college studentsBridging Levels of Understanding in Schizophrenia Through Computational Modeling.HPA-axis function, symptoms, and medication exposure in youths at clinical high risk for psychosis.Cognition-emotion dysinteraction in schizophrenia.Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosisThe role of default network deactivation in cognition and diseaseStress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders.Alternating and postictal psychoses: review and a unifying hypothesisDistinct disruptions of resting-state functional brain networks in familial and sporadic schizophrenia.Decision making: from neuroscience to psychiatryAssociation of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk.Violent behaviour among people with schizophrenia: a framework for investigations of causes, and effective treatment, and prevention.Early Life Bereavement and Schizophrenia: A Nationwide Cohort Study in Denmark and Sweden.Socioeconomic background and the developmental course of schizotypal and borderline personality disorder symptomsConnectivity, pharmacology, and computation: toward a mechanistic understanding of neural system dysfunction in schizophrenia.Risk of adult schizophrenia and its relationship to childhood IQ in the 1958 British birth cohort.The effects of physical activity on psychological well-being for those with schizophrenia: A systematic review.How aging individuals with schizophrenia experience the self-etiology of their illness: a reflective lifeworld research approach.Early-onset schizophrenia: Symptoms and social class of origin.Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date.The Effect of Fluphenazine and Thioridazine on Toxoplasma gondii In Vivo.SZDB: A Database for Schizophrenia Genetic Research.Higher prevalence of dementia in patients with schizophrenia: A nationwide population-based study.Prospective memory in schizophrenia and schizotypy.Family communication with teens at clinical high-risk for psychosis or bipolar disorder.
P2860
Q24187012-0232DA75-6D37-4034-A2C8-F2FC798B4C07Q24187667-1C71216A-4D20-4BFF-98EF-B8C89A7E4A2AQ27011733-2AF64390-D7E2-4130-A9B5-B99576F51593Q27303206-E456DD85-FDB6-4575-A68B-3A87F0D65CA4Q28073684-EBE16396-64DF-4E7A-B52C-72447A933E43Q28394341-1D711DD3-01C3-4045-B605-C2E9B5ABD288Q30416030-C115D5EF-1854-4807-9C1D-A38CE237EE7DQ33244596-4557E613-FC1A-4CE7-922F-21F1B419F1CCQ33665389-4C7848D8-CCE2-4E33-B75C-4032DBF2534CQ33762512-3D5756C1-B46F-4C12-8CA9-FBC0959290CEQ33890123-C24DC9D8-568F-4E23-9528-1D8DF65F0877Q33971149-1E49CD1E-1F7F-4E0E-AF89-86654B1DD442Q34492915-345110A1-E059-4FB0-82A2-323E056B94E8Q34531704-9CD7DDB3-7275-40FD-9E3E-DC5BA2BE95A1Q34942662-4EF35576-3C96-41A6-99B0-DEDE7CA19476Q35056687-3EF3B137-EAD9-4C83-8320-3BF7E3B6028AQ35575046-54DA1916-3019-4C60-9114-CC7F46F94A8BQ36296028-57DD265C-154D-4F9F-8234-DBAACA7C1A1DQ36314731-10A0D76C-EE46-45BE-8033-DB4633537A5DQ36386339-5988F0B6-0406-438F-810E-A4D58996A4D6Q36409725-283AB80C-5B76-4E6C-8C79-8C96692F4DFEQ36566937-BC6C5EF8-0C63-43AF-B0AE-16978C3370CAQ36751563-B152795A-3CD4-4774-9393-CD18657A7AECQ36754651-ABACAD56-E873-4104-9AC7-C668906170A1Q36897293-F20220E3-A27B-4873-8425-29D954071377Q36968057-6A6A97C5-3C61-451F-AAE0-AF751769DAB8Q37022580-5B7173DF-2E43-44AC-BEA0-5F712D07852EQ37204878-400DA8E5-C319-4E47-A445-05FF46E58CBBQ37379573-978C67CA-57E7-46F4-B7BE-BBF4179FD594Q37412196-AFF29552-A0EA-4B93-B999-6B93B2720146Q37451436-34A12133-DCC7-42C9-BEDE-93F2CDA7EAB2Q37844617-36BA81A6-052A-4BFA-B53B-86B8547742EDQ38550828-7092DC72-98B2-496E-85AF-B13C36F31661Q38658579-214F4866-5949-4B59-A4A9-C8940E23FAD9Q38770356-143942DE-BF30-4C25-BDC3-9A6F1B644A6AQ39015890-D2987DD0-B68A-45A6-9CF5-A4F76625E6DEQ39566363-0CFED07D-FD87-40A0-A59E-517C21CC74E0Q39877537-CEE85262-41C0-457C-9171-DF750E3DFE67Q45153782-E22F2A20-A2C3-4DD2-8D15-28C2F05E772FQ47639988-C14EFB02-4C3E-4A5F-BE27-075C9026E0E8
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Schizophrenia: etiology and course.
@ast
Schizophrenia: etiology and course.
@en
type
label
Schizophrenia: etiology and course.
@ast
Schizophrenia: etiology and course.
@en
prefLabel
Schizophrenia: etiology and course.
@ast
Schizophrenia: etiology and course.
@en
P2093
P1476
Schizophrenia: etiology and course.
@en
P2093
Annie Bollini
Elaine Walker
Karen M Hochman
Lisa Kestler
P304
P356
10.1146/ANNUREV.PSYCH.55.090902.141950
P577
2004-01-01T00:00:00Z